首页|脓毒症患者血清糖酵解代谢物变化及对T淋巴细胞功能的影响

脓毒症患者血清糖酵解代谢物变化及对T淋巴细胞功能的影响

扫码查看
目的 探讨脓毒症患者血清糖酵解代谢物变化及对T淋巴细胞功能的影响。方法 选取2022年8月至2023年12月德驭医疗马鞍山总医院收治的54例脓毒症患者和同期54例健康志愿者作为研究对象,采用乳酸检测试剂盒(比色法)说明书检测两组患者血清中糖酵解代谢物乳酸的含量;采用酶联免疫吸附法(ELISA)检测两组患者血清中肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β和IL-10的表达水平。H9人淋巴细胞系分为乳酸处理组和乳酸未处理组,向乳酸处理组细胞中加入8 mmol/L的乳酸,乳酸未处理组则加入等体积的生理盐水,孵育24 h。采用细胞增殖检测试剂盒(MTT法)检测增殖活力;采用流式细胞术检测T淋巴细胞亚群比例变化;采用荧光定量聚合酶链反应(PCR)分析TNF-α、1L-1β、IL-10 mRNA表达水平。结果 脓毒症患者血清中乳酸水平[(5。51±1。14)mmol/L]明显高于对照组[(2。01±0。66)mmol/L],差异有统计学意义(t=18。74,P<0。05)。脓毒症患者血清中 TNF-α[(240。38±58。50)pg/ml]和 IL-1β[(117。39±16。35)pg/ml]水平明显高于对照组[(78。52±14。87)、(35。89±8。34)pg/ml],IL-10[(35。43±8。58)pg/ml]水平明显低于对照组[(99。21±14。76)pg/ml,差异有统计学意义(t=18。96、31。40、26。42,P<0。05)。乳酸处理组细胞(0。74±0。04)的吸光度值明显低于乳酸未处理组(1。24±0。08),差异有统计学意义(t=13。56,P<0。05)。乳酸处理组细胞的CD8+T淋巴细胞比例[(27。07±1。18)%]明显高于乳酸未处理组[(23。70±0。98)%],CD4+T 淋巴细胞比例[(29。52±0。74)%]、CD4+/CD8+T 比值(1。09±0。04)明显低于乳酸未处理组[(34。92±2。81)%、(1。47±0。12)],差异有统计学意义(t=5。40、4。55、7。24,P<0。05)。乳酸处理组细胞的 TNF-α(1。18±0。08)和 IL-1 β(1。32±0。07)mRNA水平明显高于乳酸未处理组(0。47±0。04、0。59±0。06),IL-10(0。56±0。06)mRNA水平明显低于乳酸未处理组(1。05±0。09),差异有统计学意义(t=19。90、18。51、11。68,P<0。05)。结论 脓毒症患者血清中糖酵解代谢物乳酸水平显著增加。乳酸水平的升高可通过抑制T淋巴细胞的增殖和分化,调控炎性因子的水平,最终导致细胞免疫功能受损。
Changes of serum glycolytic metabolites and their effects on T lymphocyte function in patients with sepsis
Objective To investigate the changes of serum glycolytic metabolites and their effects on T lymphocyte function in patients with sepsis.Methods A total of 54 patients with sepsis admitted to our hospital from August 2022 to December 2023 and 54 healthy volunteers during the same period were se-lected as the study objects.Lactic acid detection kit(colorimetric method)was used to detect the content of serum lactic acid in the two groups.The expression of tumor necrosis factor-α(TNF-α),interleukin(IL)-1β and IL-10 in serum of the two groups was detected by enzyme-linked immunosorbent assay(ELISA).H9 human lymphoid cell lines were divided into lactic acid treated group and untreated group.8 mmol/L of lactic acid was added to the lactic acid treated group,and equal volume of normal saline was added to the the untreated group,and H9 cells were incubated for 24 h.Cell proliferation assay kit(MTT method)was used to detect proliferation activity.The proportion of T lymphocyte subsets was detected by flow cytometry.The mRNA expression of TNF-α,IL-1β and IL-10 was analyzed by fluorescence quantita-tive polymerase chain reaction(PCR).Results The lactic acid level in sepsis patients[(5.51±1.14)mmol/L]was significantly higher than that in control group[(2.01±0.66)mmol/L,t=18.74,P<0.05].The levels of TNF-α[(240.38±58.50)pg/ml]and IL-1 β[(117.39±16.35)pg/ml]in sepsis patients were significantly higher than those of control patients[(78.52±14.87),(35.89±8.34)pg/ml],whereas the IL-10[(35.43±8.58)pg/ml]level significantly lower than the control group[(99.21±14.76)pg/ml,t=18.96,31.40,26.42,P<0.05].The absorbance in lactic acid treated group(0.74±0.04)was significantly lower than in untreated group(1.24±0.08,t=13.56,P<0.05).The percentage of CD8+T lymphocytes[(27.07±1.18)%]in lactic acid treated group was significantly high-er than that in untreated group[(23.70±0.98)%].The percentage of CD4+T lymphocytes[(29.52±0.74)%]and CD4+/CD8+T ratio(1.09±0.04)in lactic acid treated group were significantly lower than those in untreated group[(34.92±2.81)%,1.47-0.12,t=5.40,4.55,7.24,P<0.05].The mRNA expression of TNF-α(1.18±0.08)and IL-1β(1.32±0.07)in lactic acid treated group was significantly higher than that in untreated group(0.47±0.04,0.59±0.06),whereas IL-10(0.56±0.06)was signif-icantly lower than that of untreated group(1.05±0.09,t=19.90,18.51,11.68,P<0.05).Conclu-sion The serum levels of lactic acid increased significantly in patients with sepsis.The increase of lactic acid can regulate the level of inflammatory factors by inhibiting the proliferation and differentiation of T lym-phocytes,and ultimately lead to impaired cellular immune function.

SepsisLactic acidT lymphocytesImmune function

郁帆、唐建辉、杨志军、孙小明

展开 >

德驭医疗马鞍山总医院重症医学科,马鞍山 243000

脓毒症 乳酸 T淋巴细胞 免疫功能

2022年度皖南医学院科研项目

LC202204

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(8)